OrbiMed Advisors Israel II Ltd
- SEC CIK
- 0001682093
In the past year, 2 open-market purchase filings worth $21.1M and 1 sale filing worth $674.8K.
Current role at each company
- ADRX ADARx Pharmaceuticals, Inc.Director, 10% Owneras of Sep 30, 2026
- ACET Adicet Bio, Inc.10% Owneras of Apr 9, 2026
- UPB Upstream Bio, Inc.Director, 10% Owneras of Oct 17, 2024
- DMRA Damora Therapeutics, Inc.10% Owneras of Aug 17, 2023
- ETNB 89bio, Inc.10% Owneras of Jan 27, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $21.1M
- 2 filings
- Sold
- $674.8K
- 1 filing
- Net
- +$20.5M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists OrbiMed Advisors Israel II Ltd as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ADRX ADARx Pharmaceuticals, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 (view filing)5:23 PM ET | Sep 28 | 2 days | OrbiMed Advisors LLC and 4 othersDirector, 10% Owner | PPurchase | +950.0K | $17.00 | +$16.1M | New position588.2K after | 3 lots |
ACET Adicet Bio, Inc.
10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2026 (view filing)5:38 PM ET | Apr 7-8 | 2 days | OrbiMed Advisors LLC and 7 others10% Owner | SSale | −104.7K | $6.45 | −$674.8K | −100.0%0 after | 4 lots |
| Oct 10, 2025 (view filing)8:06 PM ET | Oct 8 | 2 days | OrbiMed Advisors LLC and 7 others10% Owner | PPurchase | +5.00M | $1.00 | +$5.00M | New position4.49M after | 2 lots |
| Jan 26, 2024 (view filing)7:14 PM ET | Jan 25 | 1 day | OrbiMed Advisors LLC and 7 othersDirector, 10% Owner | PPurchase | +3.13M | $2.40 | +$7.50M | New position1.26M after | 3 lotsDuplicate filing |
| Jun 29, 2023 (view filing)4:46 PM ET | Jun 27 | 2 days | OrbiMed Advisors LLC and 8 othersDirector, 10% Owner | PPurchase | +875.0K | $2.09 | +$1.83M | New position748.1K after | 4 lotsDuplicate filing |
UPB Upstream Bio, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 17, 2024 (view filing)4:17 PM ET | Oct 15 | 2 days | OrbiMed Advisors LLC and 3 othersDirector, 10% Owner | PPurchase | +825.0K | $17.00 | +$14.0M | +22.1%4.55M after | 2 lotsDuplicate filing |
DMRA Damora Therapeutics, Inc.
10% Owner7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2023 (view filing)4:40 PM ET | Aug 15 | 2 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −822.7K | $0.75 | −$617.0K | −35.3%1.51M after | 3 lots |
| Aug 2, 2023 (view filing)5:05 PM ET | Jul 31 | 2 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −209.4K | $3.00 | −$628.2K | −9.0%2.11M after | 3 lots |
| Jul 27, 2023 (view filing)4:28 PM ET | Jul 25 | 2 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −39.2K | $2.92 | −$114.5K | −1.7%2.26M after | 3 lots |
| Jul 17, 2023 (view filing)4:13 PM ET | Jul 13 | 4 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −194.7K | $2.40 | −$467.3K | −7.8%2.29M after | 3 lots |
| Apr 17, 2023 (view filing)5:28 PM ET | Apr 13-17 | 4 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −68.5K | $1.87 | −$128.3K | −2.8%2.42M after | 9 lots |
| Apr 12, 2023 (view filing)6:44 PM ET | Apr 10-12 | 2 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −67.5K | $1.80 | −$121.4K | −2.7%2.46M after | 9 lots |
| Apr 7, 2023 (view filing)4:42 PM ET | Apr 5-6 | 2 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −102.6K | $2.16 | −$222.0K | −3.9%2.51M after | 6 lots |
ETNB 89bio, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2022 (view filing)5:22 PM ET | Jan 25-26 | 2 days | OrbiMed Advisors LLC and 3 others10% Owner | SSale | −70.6K | $8.39 | −$592.4K | −3.7%1.83M after | 4 lots |